Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107,228,372
-
Total 13F shares
-
49,065,584
-
Share change
-
+6,283,607
-
Total reported value
-
$735,942,854
-
Put/Call ratio
-
667%
-
Price per share
-
$15.00
-
Number of holders
-
96
-
Value change
-
+$92,556,483
-
Number of buys
-
70
-
Number of sells
-
19
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q2 2019
As of 30 Jun 2019 ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) had 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 49,065,584 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Cormorant Asset Management, LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BOXER CAPITAL, LLC, FMR LLC, and BRIDGER MANAGEMENT, LLC.
This table shows 96 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.